Double Blinded, Placebo Controlled Trial of Alpha Interferon Therapy for West Nile Meningoencephalitis

Trial Profile

Double Blinded, Placebo Controlled Trial of Alpha Interferon Therapy for West Nile Meningoencephalitis

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Sep 2007

At a glance

  • Drugs Interferon alpha-n3 (Primary)
  • Indications Meningoencephalitis; West Nile virus infections
  • Focus Therapeutic Use
  • Sponsors Hemispherx Biopharma
  • Most Recent Events

    • 13 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top